Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiro Shirakawa

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Urology|April 3, 2002
Estrogen levels influence beta-3-adrenoceptor-mediated relaxation of the female rat detrusor muscleShigeji Matsubara, Hiroshi Okada, Toshiro Shirakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2006
Rapid detection of the fluoroquinolone resistance-associated ParC mutation in Neisseria gonorrhoeae using TaqMan probesKatsumi Shigemura, Toshiro Shirakawa, Kazushi Tanaka, et al.
Urology|March 18, 2003
Complete resection of synovial sarcoma of prostatic fasciaToshiro Shirakawa, Masato Fujisawa, Akinobu Gotoh, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoterKatsuyuki Hamada, Toshiro Shirakawa, Shuji Terao, et al.
International Journal of Antimicrobial Agents|October 17, 2012
Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis studyKatsumi Shigemura, Kazushi Tanaka, Fukashi Yamamichi, et al.
Anticancer Research|August 6, 2005
Recombinant interleukin-2 enhanced the antitumor effect of ADV/RSV-HSV-tk/ACV therapy in a murine bladder cancer modelShuji Terao, Toshiro Shirakawa, Kazumasa Goda, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|March 18, 2005
Quantitative detection of Escherichia coli from urine of patients with bacteriuria by real-time PCRNobuyuki Hinata, Toshiro Shirakawa, Hiroshi Okada, et al.
Urology|December 20, 2005
Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivoKatsumi Shigemura, Toshiro Shirakawa, Yoshitaka Wada, et al.
The Journal of Antibiotics|April 17, 2014
Comparison between phage-open-reading frame typing and automated repetitive-sequence-based PCR for typing MRSA isolatesKayo Osawa, Katsumi Shigemura, Takumi Jikimoto, et al.
Urology|August 28, 2012
Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B)Fukashi Yamamichi, Takayuki Matsuoka, Katsumi Shigemura, et al.
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Urology|April 3, 2002
Estrogen levels influence beta-3-adrenoceptor-mediated relaxation of the female rat detrusor muscleShigeji Matsubara, Hiroshi Okada, Toshiro Shirakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2006
Rapid detection of the fluoroquinolone resistance-associated ParC mutation in Neisseria gonorrhoeae using TaqMan probesKatsumi Shigemura, Toshiro Shirakawa, Kazushi Tanaka, et al.
Urology|March 18, 2003
Complete resection of synovial sarcoma of prostatic fasciaToshiro Shirakawa, Masato Fujisawa, Akinobu Gotoh, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoterKatsuyuki Hamada, Toshiro Shirakawa, Shuji Terao, et al.
International Journal of Antimicrobial Agents|October 17, 2012
Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis studyKatsumi Shigemura, Kazushi Tanaka, Fukashi Yamamichi, et al.
Anticancer Research|August 6, 2005
Recombinant interleukin-2 enhanced the antitumor effect of ADV/RSV-HSV-tk/ACV therapy in a murine bladder cancer modelShuji Terao, Toshiro Shirakawa, Kazumasa Goda, et al.
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology|March 18, 2005
Quantitative detection of Escherichia coli from urine of patients with bacteriuria by real-time PCRNobuyuki Hinata, Toshiro Shirakawa, Hiroshi Okada, et al.
Urology|December 20, 2005
Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivoKatsumi Shigemura, Toshiro Shirakawa, Yoshitaka Wada, et al.
The Journal of Antibiotics|April 17, 2014
Comparison between phage-open-reading frame typing and automated repetitive-sequence-based PCR for typing MRSA isolatesKayo Osawa, Katsumi Shigemura, Takumi Jikimoto, et al.
Urology|August 28, 2012
Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B)Fukashi Yamamichi, Takayuki Matsuoka, Katsumi Shigemura, et al.
Pageof 15